| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group
|
Fleischmann, Maximilian
|
|
|
34 |
C |
p. 99-106
|
artikel
|
| 2 |
A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology
|
Brown, Kathryn H.
|
|
|
34 |
C |
p. 112-119
|
artikel
|
| 3 |
Availability of technology for managing cancer patients in the Southeast European (SEE) region
|
Dosanjh, Manjit
|
|
|
34 |
C |
p. 57-66
|
artikel
|
| 4 |
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group
|
Barcellini, Amelia
|
|
|
34 |
C |
p. 1-6
|
artikel
|
| 5 |
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity
|
Thomsen, A.R.
|
|
|
34 |
C |
p. 51-56
|
artikel
|
| 6 |
BRIDGE −1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial
|
Chiloiro, Giuditta
|
|
|
34 |
C |
p. 30-36
|
artikel
|
| 7 |
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
|
Liermann, Jakob
|
|
|
34 |
C |
p. 15-22
|
artikel
|
| 8 |
Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation
|
Boekhoff, M.R.
|
|
|
34 |
C |
p. 82-89
|
artikel
|
| 9 |
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia
|
Ghandourh, Wsam
|
|
|
34 |
C |
p. 7-14
|
artikel
|
| 10 |
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma
|
Göbel, Holger H.
|
|
|
34 |
C |
p. 90-98
|
artikel
|
| 11 |
Post-treatment neuroendocrine outcomes among pediatric brain tumor patients: Is there a difference between proton and photon therapy?
|
Yip, Anthony T.
|
|
|
34 |
C |
p. 37-41
|
artikel
|
| 12 |
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy
|
Ahmadsei, Maiwand
|
|
|
34 |
C |
p. 23-29
|
artikel
|
| 13 |
“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”
|
Angrisani, A.
|
|
|
34 |
C |
p. 67-74
|
artikel
|
| 14 |
Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma
|
Lucas Jr., John Thomas
|
|
|
34 |
C |
p. 42-50
|
artikel
|
| 15 |
The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey
|
Krishnamurthy, Sapna
|
|
|
34 |
C |
p. 75-81
|
artikel
|
| 16 |
Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life
|
Christ, Sebastian M.
|
|
|
34 |
C |
p. 107-111
|
artikel
|
Tijdschrift beschrijving